Mon, November 5, 2018

Salveen Richter Initiated (ALLO) at Strong Buy and Held Target at $41 on, Nov 5th, 2018

Salveen Richter of Goldman Sachs, Initiated "Allogene Therapeutics, Inc." (ALLO) at Strong Buy and Held Target at $41 on, Nov 5th, 2018.

Salveen, nor any peers, have made any analyst calls on ALLO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30